Liver Specialists of Texas no http://www.texasliver.com/en/rss Liver Specialists of Texas http://www.texasliver.com/images/podcastlogo.jpg http://www.texasliver.com Copyright 2010 Liver Specialists of Texas Tendenci Association Software by Schipul - The Web Marketing Company en-us noemail@texasliver.com Fri, 10 Sep 2010 20:57:40 GMT Release http://www.texasliver.com/en/rel/11/ Houston Based Liver Specialists of Texas is Seeking Internists for Their Growing Hepatology and Liver Transplant Program Internists are needed to expand within a busy clinical Hepatology and Liver Transplant practice, caring for the Internal Medicine needs of patients with all facets of liver disease. Disease management of hypertension, renal disease, hyperlipidemia, obesity, metabolic syndrome, and endocrine disorders in a supportive environment, located in the world’s largest medical center, has openings for April, July, and December 2010. Houston, TX, January 25, 2010: Internist needed for Hepatology and Liver Transplant Program. Located in Houston’s world-famous Texas Medical Center, we are seeking an energetic BC/BE internist to join a well established and respected program. This physician will care for the internal medicine needs of patients with liver disease and recipients of liver transplants in an integrated fashion. Clinical support from hepatologists,... http://www.texasliver.com/en/rel/11/ noemail@texasliver.com Mon, 25 Jan 2010 14:00:00 GMT Release http://www.texasliver.com/en/rel/2/ Dr. Joseph S. Galati and Liver Specialists of Texas are pleased to announce the start of a new investigational study for patients with hepatitis C. As of September 2009, we will be having additional investigational studies for patients with hepatitis C. The studies are classified for patients based on any prior treatment for HCV. Naive patients have never received any form of anti-viral therapy for hepatitis C. This would include Rebetron, Intron A, Ribavirin, PEG-Intron, Pegasys, or Infergen. Other classes of patients will include those previously treated with any of the above drugs. Further, patients will be classified as either responder-relapsers, or non-responders. Once we are able to screen your records, we can detwrmine if you could participate in any of the studies. There are several large companies sponsoring these studies, with a number of very exciting medications that will be used. The basic inclusion criteria for these study include: male or female... http://www.texasliver.com/en/rel/2/ noemail@texasliver.com Thu, 25 Sep 2008 23:00:00 GMT